TrialNature medicine2020

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma.

Fathima Zumla Cader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.